
News|Videos|September 5, 2017
Using Patient Variables in CML to Guide Treatment
Author(s)Ruediger Hehlmann, MD
This video highlights patient variables, including kidney function or history of diabetes, that can help guide treatment in chronic myeloid leukemia.
Advertisement
In this video, Ruediger Hehlmann, MD, of the University of Heidelberg in Germany, discusses patient variables-including kidney function or history of diabetes-that can help guide treatment in chronic myeloid leukemia (CML), and reviews the need for molecular monitoring for disease relapse.
Hehlmann spoke on this topic during an education session at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Tazemetostat Withdrawn From Follicular Lymphoma, Sarcoma Markets
2
Treating Young Patients With Colorectal Cancer: Talking With a Surgeon
3
FDA Issues CRL for Retifanlimab/Chemotherapy in Metastatic NSCLC
4
Dismantling Barriers to Early Adoption of Bispecifics in Multiple Myeloma
5
























































